A stochastic model of HIV infection incorporating combined therapy of HAART driven by Lévy jumps
From MaRDI portal
Publication:2114336
Recommendations
- A dynamics stochastic model with HIV infection of CD4\(^+\) T-cells driven by Lévy noise
- A stochastic HIV infection model with latent infection and antiretroviral therapy
- A stochastic HIV infection model with T-cell proliferation and CTL immune response
- Dynamics of an HIV-1 infection model with cell-mediated immune response and stochastic perturbation
- A stochastic analysis of HIV infection in the presence of therapeutic intervention
Cites work
- A delay differential equation model of HIV infection of \(\text{CD4}^{+}T\)-cells with cure rate
- A delay-differential equation model of HIV infection of \(\text{CD}4^+\) T-cells
- A model incorporating combined RTIs and PIs therapy during early HIV-1 infection
- A model of HIV-1 infection with two time delays: mathematical analysis and comparison with patient data
- A model of HIV-1 pathogenesis that includes an intracellular delay
- A stochastic model for internal HIV dynamics
- Complex dynamics in a stochastic internal HIV model
- Delay differential model for tumour–immune dynamics with HIV infection of CD4+T-cells
- Dynamics of a stochastic HIV-1 infection model with logistic growth
- Dynamics of a stochastic one-prey two-predator model with Lévy jumps
- Dynamics of a stochastic regime-switching predator-prey model with harvesting and distributed delays
- Dynamics of an HIV-1 infection model with cell-mediated immune response and stochastic perturbation
- Dynamics of cytotoxic T-lymphocytes and helper cells in human immunodeficiency virus infection with Hill-type infection rate and sigmoidal CTL expansion
- Global stability analysis of HIV-1 infection model with three time delays
- Impact of intracellular delays and target-cell dynamics on in vivo viral infections
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy.
- Nature of equilibria and effects of drug treatments in some simple viral population dynamical models
- Permanence and extinction for a single-species system with jump-diffusion
- Persistence and extinction of a modified Leslie-Gower Holling-type II stochastic predator-prey model with impulsive toxicant input in polluted environments
- Reinsurer's optimal reinsurance strategy with upper and lower premium constraints under distortion risk measures
- Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics
- Simulation and approximation of Lévy-driven stochastic differential equations
- Stochastic SIR model with jumps
- Stochastic modeling of the dynamics of CD4^ + T-cell infection by HIV and some Monte Carlo studies
- Stochastic stability for nonlinear systems driven by Lévy noise
- The Euler scheme for Lévy driven stochastic differential equations
- The threshold of a stochastic SIS epidemic model with vaccination
- Threshold of a stochastic SIR epidemic model with Lévy jumps
- Within-host demographic fluctuations and correlations in early retroviral infection
Cited in
(6)- A stochastic HIV infection model with latent infection and antiretroviral therapy
- The long-time behavior of a stochastic SIR epidemic model with distributed delay and multidimensional Lévy jumps
- The influence of Lévy noise on the dynamical behavior of a stochastic HIV/AIDS model with vertical transmission
- A stochastic analysis of HIV infection in the presence of therapeutic intervention
- The influence of quadratic Lévy noise on the dynamic of an SIC contagious illness model: new framework, critical comparison and an application to COVID-19 (SARS-CoV-2) case
- A dynamics stochastic model with HIV infection of CD4\(^+\) T-cells driven by Lévy noise
This page was built for publication: A stochastic model of HIV infection incorporating combined therapy of HAART driven by Lévy jumps
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2114336)